Papalexis Nicolas, Peta Giuliano, Errani Costantino, Miceli Marco, Facchini Giancarlo
Department of Diagnostic and Interventional Radiology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Department of Diagnostic and Interventional Radiology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
J Vasc Interv Radiol. 2023 Apr;34(4):608-612. doi: 10.1016/j.jvir.2022.11.030. Epub 2022 Dec 5.
To investigate the efficacy and safety of preoperative arterial embolization for neurogenic heterotopic ossification (NHO) of the hip.
This single-center retrospective study reviewed outcomes in 16 consecutive patients who had surgical resection of NHO of the hip: 8 of whom underwent preoperative arterial embolization and 8 of whom did not. Both patient cohorts had similar baseline characteristics. A mean of 2.62 ± 1.9 arteries per patient, including the gluteal, lateral circumflex femoral, and deep circumflex iliac branches, were embolized using an n-butyl cyanoacrylate (NBCA)-ethiodized oil mixture. Data from both cohorts regarding intraoperative blood loss, volume of blood transfused, complications, and duration of hospitalization were compared.
A mean of 2.6 ± 1.9 arteries were embolized with NBCA-ethiodized oil, mainly the gluteal arteries, lateral circumflex femoral artery, and deep circumflex iliac artery. In the embolization group, mean intraoperative blood loss was 875 mL ± 320, mean number of units of blood used was 0.5 ± 0.7, and mean number of days of hospitalization was 6.4 days ± 1.6. In the control group, mean intraoperative blood loss was 1,350 mL ± 120, mean number of units of blood used was 2 ± 1.1, and average number of days of hospitalization was 11.5 days ± 1.4. The embolization group had a mean reduction in blood loss of 40.7% (P = 0.035), reduction in units of blood administered of 75% (P = 0.021), and reduction in days of hospitalization of 44.7% (P = 0.014). No procedural complications were recorded.
Preoperative arterial embolization is effective and safe in reducing intraoperative blood loss, number of hospitalization days, and need for blood transfusions in surgical resection of NHO of the hip.
探讨术前动脉栓塞治疗髋关节神经源性异位骨化(NHO)的疗效和安全性。
本单中心回顾性研究回顾了16例连续接受髋关节NHO手术切除患者的结局:其中8例接受了术前动脉栓塞,8例未接受。两个患者队列具有相似的基线特征。使用氰基丙烯酸正丁酯(NBCA)-碘化油混合物栓塞每位患者平均2.62±1.9条动脉,包括臀动脉、旋股外侧动脉和旋髂深动脉分支。比较两个队列关于术中失血量、输血量、并发症和住院时间的数据。
平均用NBCA-碘化油栓塞2.6±1.9条动脉,主要是臀动脉、旋股外侧动脉和旋髂深动脉。在栓塞组中,平均术中失血量为875 mL±320,平均输血量为0.5±0.7单位,平均住院天数为6.4天±1.6天。在对照组中,平均术中失血量为1350 mL±120,平均输血量为2±1.1单位,平均住院天数为11.5天±1.4天。栓塞组平均失血量减少40.7%(P = 0.035),输血量减少75%(P = 0.021),住院天数减少44.7%(P = 0.014)。未记录到手术并发症。
术前动脉栓塞在减少髋关节NHO手术切除术中的失血量、住院天数和输血需求方面是有效且安全的。